Biotech and Pharmaceuticals

Merck on Thursday topped third-quarter estimates and hiked its adjusted profit outlook, as its immunotherapy…
Read More...

"This medicine could be one of our largest medicines in history," Novartis CEO Vas Narasimhan told CNBC on Tuesday,…
Read More...

Eli Lilly on Thursday reported third-quarter earnings and revenue that blew past estimates and hiked its full-year…
Read More...

Leaked confidential data. A major stock sell-off. Beneath the chaos surrounding Moderna and Merck's latest data on…
Read More...

Novo on Tuesday said its next-generation obesity drug, CagriSema, showed 25% weight loss on average among adult women…
Read More...

What a week to have a Monthly Meeting. On Thursday, Jim Cramer and portfolio director Jeff Marks held our October…
Read More...

Walmart plans to cover more than 250 prescriptions, including some insulin, inhalers and GLP-1s for diabetes, at no…
Read More...

Former drug company executive Martin Shkreli and his lead attorney Benjamin Brafman arrive at U.S. District Court for…
Read More...

AstraZeneca CEO Pascal Soriot told CNBC on Monday that Summit Therapeutics' lead drug could help power…
Read More...

Novartis has signed a deal worth up to $7.8 billion, in the latest of a flurry of tie-ups between Big Pharma and…
Read More...